Chevy Chase Trust Holdings Inc. Reduces Stake in Humana Inc. (HUM)
Chevy Chase Trust Holdings Inc. cut its position in Humana Inc. (NYSE:HUM) by 2.3% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 125,772 shares of the insurance provider’s stock after selling 2,923 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.08% of Humana worth $22,248,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. RidgeWorth Capital Management LLC bought a new stake in Humana during the second quarter worth approximately $75,609,000. FMR LLC boosted its stake in Humana by 21.5% in the second quarter. FMR LLC now owns 1,876,497 shares of the insurance provider’s stock worth $337,544,000 after buying an additional 331,537 shares during the last quarter. BlackRock Investment Management LLC boosted its stake in Humana by 34.3% in the second quarter. BlackRock Investment Management LLC now owns 950,666 shares of the insurance provider’s stock worth $171,006,000 after buying an additional 242,769 shares during the last quarter. Emerald Acquisition Ltd. bought a new stake in Humana during the second quarter worth approximately $39,669,000. Finally, Vanguard Group Inc. boosted its stake in Humana by 2.5% in the second quarter. Vanguard Group Inc. now owns 8,964,492 shares of the insurance provider’s stock worth $1,612,532,000 after buying an additional 219,311 shares during the last quarter. Institutional investors and hedge funds own 93.94% of the company’s stock.
Humana Inc. (NYSE:HUM) opened at 200.16 on Friday. Humana Inc. has a 52 week low of $150.00 and a 52 week high of $202.40. The company’s 50-day moving average is $175.40 and its 200 day moving average is $175.64. The stock has a market cap of $29.84 billion, a PE ratio of 27.07 and a beta of 0.80.
Humana (NYSE:HUM) last announced its quarterly earnings data on Friday, November 4th. The insurance provider reported $3.18 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.09 by $0.09. Humana had a net margin of 2.00% and a return on equity of 12.32%. The company had revenue of $13.69 billion for the quarter, compared to the consensus estimate of $13.41 billion. During the same period in the prior year, the firm posted $2.16 EPS. Humana’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, analysts expect that Humana Inc. will post $9.51 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Thursday, January 12th will be issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date of this dividend is Tuesday, January 10th. Humana’s payout ratio is presently 15.96%.
HUM has been the subject of a number of analyst reports. JPMorgan Chase & Co. upgraded shares of Humana from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $163.00 to $202.00 in a report on Thursday, November 10th. Argus reiterated a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Barclays PLC reiterated a “hold” rating and set a $191.00 price objective on shares of Humana in a report on Monday, November 7th. Credit Suisse Group AG upgraded shares of Humana from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $175.00 to $210.00 in a report on Friday, November 11th. Finally, Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 price objective for the company in a report on Tuesday, October 4th. Five research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Humana currently has an average rating of “Buy” and a consensus target price of $205.00.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.